Wilmington, NCNCT06143514Now EnrollingIRB Ready

Relapsing Multiple Sclerosis Clinical Trial in Wilmington, NC

Access cutting-edge relapsing multiple sclerosis treatment through this clinical trial at a research site in Wilmington. Study-provided care at no cost to qualified participants.

Sponsored by TG Therapeutics, Inc.

Quick Self-Assessment

See if you qualify for this Wilmington location

Preparing your pre-screening questions…

Expert Care in Wilmington

Access relapsing multiple sclerosis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related relapsing multiple sclerosis treatment provided free

Apply for This Wilmington Location

Check if you qualify for this relapsing multiple sclerosis clinical trial in Wilmington, NC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Wilmington

    Convenient for NC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Wilmington site if eligible
  4. 4Begin participation

About This Relapsing Multiple Sclerosis Study in Wilmington

The primary objective of the lactation study is to characterize the presence and concentration of BRIUMVI™ in breast milk among breastfeeding participants who receive BRIUMVI™ therapeutically for the treatment of relapsing forms of multiple sclerosis (RMS).

Sponsor: TG Therapeutics, Inc.

Who Can Participate

Inclusion Criteria

Maternal Criteria:
Participant has independently decided to be treated with BRIUMVI™ prior to providing consent to participate in the study
Diagnosis of RMS, to include clinically isolated syndrome (CIS), relapsing-remitting multiple sclerosis (RRMS), and active secondary progressive multiple sclerosis (SPMS)
Willing to breastfeed or pump regularly during the study period to maintain milk supply and exclusively pump breast milk for the 24-hour period of breast milk collection Day 1 post IV dose
Plans to continue feeding infant breast milk at least throughout the duration of the study and is not weaning Infant Criteria:
Gestational age at delivery ≥35 weeks
Birthweight \> 10th percentile
Weight \> 10th percentile as reported by the mother at the time of enrollment

Exclusion Criteria

Maternal Criteria:
Any active infection or other condition that would prevent the individual from breastfeeding
History of breast implants, breast augmentation, or breast reduction surgery that significantly impacts breastfeeding or collection of milk from 1 or both breasts
History of mastectomy
Evidence of mastitis or any other significant active infection at Day 1 (pre-dose) that would prevent collection of milk from one or both breasts
Current use of drugs known to transfer to the breast milk and with established or potential deleterious effects for the infant, including but not limited to aspirin (risk of Reye's syndrome), tetracyclines or fluoroquinolones Infant Criteria: \- Any abnormality noted or clinically significant medical condition, including cardiac, pulmonary, and liver disease, glucose instability, or active infection at the time of screening that, in the opinion of the investigator, may make implementation of the protocol or interpretation of the trial difficult or would put the infant at risk by participating in the study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Wilmington?

Yes, this clinical trial (NCT06143514) has an active research site in Wilmington, NC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Relapsing Multiple Sclerosis Treatment Options in Wilmington, NC

If you're searching for relapsing multiple sclerosis treatment options in Wilmington, NC, this clinical trial (NCT06143514) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Wilmington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced relapsing multiple sclerosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all relapsing multiple sclerosis clinical trials near you to find additional studies recruiting in your area.

More Multiple Sclerosis Trials in Wilmington, NC

See all multiple sclerosis clinical trials recruiting in Wilmington — not just this study.

Browse Multiple Sclerosis Trials in Wilmington →

Browse More Trials by Condition

Multiple Sclerosis TrialsAntiphospholipid Syndrome TrialsAll Conditions →

Ready to Join in Wilmington?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Wilmington, NC